NAPSA Human

Data sheet

Formulation

NAPSA protein solution (0.25mg/ml) containing 20mM Tris-HCl (pH8.0) and 10% glycerol.

Purity

Greater than 90.0% as determined by SDS-PAGE.

Description

NAPSA Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 380 amino acids (64-420 a.a) and having a molecular mass of 40.9kDa. NAPSA is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary c

Protein Background

Napsin A Aspartic Peptidase, also known as NAPSA is a member of the peptidase A1 family. NAPSA is involved in the processing of pneumocyte surfactant precursors. Furthermore the activation peptides of aspartic proteinases take part as inhibitors of the ac

Expression host

Escherichia Coli.

Synonyms

Napsin A Aspartic Peptidase, NAP1, NAPA, Kidney-Derived Aspartic Protease-Like Protein, Aspartyl Protease 4, TA01/TA02, Napsin-1, SNAPA, Asp 4, ASP4, CTB-191K22.6, EC 3.4.23.15, Pronapsin A, EC 3.4.23.5, EC 3.4.23.3, EC 3.4.23.-, EC 3.4.23, Napsin-A, KD

Reagent Appearance

Sterile filtered colorless solution.

Stability

Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles.

Amino acid sequence

MGSSHHHHHH SSGLVPRGSH MGSKPIFVPL SNYRDVQYFG EIGLGTPPQN FTVAFDTGSS NLWVPSRRCH FFSVPCWLHH RFDPKASSSF QANGTKFAIQ YGTGRVDGIL SEDKLTIGGI KGASVIFGEA LWEPSLVFAF AHFDGILGLG FPILSVEGVR PPMDVLVEQG LLDKPVFSFY LNRDPEEPDG GELVLGGSDP AHYIPPLTFV PVTVPAYWQI HMERVKVGPG L